JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Merkel, L. A.
Right arrow Articles by Perrone, M. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Merkel, L. A.
Right arrow Articles by Perrone, M. H.

Demonstration of vasorelaxant activity with an A1-selective adenosine agonist in porcine coronary artery: involvement of potassium channels

LA Merkel, RW Lappe, LM Rivera, BF Cox and MH Perrone

Rhone-Poulenc Rorer Central Research, King of Prussia, Pennsylvania.

The vasodilator activity of adenosine has been associated with selective stimulation of A2 receptors. In the present study, the vasorelaxant (VR) activity of an A1-selective agonist, CPA (cyclopentyladenosine), was examined in isolated porcine coronary arterial rings precontracted with prostaglandin F2 alpha and compared to the A2-selective agonist DPMA (N6-[2-(3,5-dimethoxyphenyl)-2-(2- methylphenyl)-ethyl] adenosine). DPMA, approximately 13-fold selective for the rat brain A2 receptor, relaxed isolated coronary arterial rings with an EC50 of 0.59 +/- 0.19 microM (n = 23) whereas CPA, 2200-fold selective for the rat brain A1 receptor, was approximately 5-fold less potent with an EC50 of 3.18 +/- 0.6 microM (n = 11). At low concentrations (10-300 nM) CPA caused vasoconstriction, indicative of the A1-selective nature of this agonist. CGS 15943 (100 nM), a nonselective adenosine antagonist, attenuated the VR activity of DPMA and CPA, causing a 9- and 12-fold rightward shift of the dose-response curves, respectively, whereas 8-cyclopentyl-1,3-dipropylxanthine (20 nM), a highly A1-selective blocker, had no such effect. Both adenosine antagonists abolished the vasoconstrictor response of CPA at low concentrations. The contributions of the cyclic GMP pathway to adenosine-induced VR was assessed using an inhibitor of endothelium- dependent relaxing factor (L-nitroarginine). L-nitroarginine had no effect on the EC50 for CPA-induced VR and, marginally, but not significantly, attenuated DPMA effects. Moreover, no elevation in cyclic GMP levels could be observed in tissues stimulated with CPA or DPMA.(ABSTRACT TRUNCATED AT 250 WORDS)

Volume 260, Issue 2, pp. 437-443, 02/01/1992
Copyright © 1992 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. E. Tawfik, B. Teng, R. R. Morrison, J. Schnermann, and S. J. Mustafa
Role of A1 adenosine receptor in the regulation of coronary flow
Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H467 - H472.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
C. J. Ray and J. M. Marshall
The cellular mechanisms by which adenosine evokes release of nitric oxide from rat aortic endothelium
J. Physiol., January 1, 2006; 570(1): 85 - 96.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
T. J. Bivalacqua, H. C. Champion, D. G. Lambert, and P. J. Kadowitz
Vasodilator responses to adenosine and hyperemia are mediated by A1 and A2 receptors in the cat vascular bed
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2002; 282(6): R1696 - R1709.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C.-W. Chen, H.-Y. Chang, and T.-R. Hsiue
Mechanism of adenosine-induced vasodilation in rat diaphragm microcirculation
Am J Physiol Heart Circ Physiol, November 1, 2000; 279(5): H2210 - H2217.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
V. Ralevic and G. Burnstock
Receptors for Purines and Pyrimidines
Pharmacol. Rev., September 1, 1998; 50(3): 413 - 492.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. S Davie and N. B Standen
Enhancement of the vasorelaxant potency of nicorandil by metabolic inhibition and adenosine in the pig coronary artery
Cardiovasc Res, March 1, 1998; 37(3): 791 - 798.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
V. N. Mutafova-Yambolieva and K. D. Keef
Adenosine-induced hyperpolarization in guinea pig coronary artery involves A2b receptors and KATP channels
Am J Physiol Heart Circ Physiol, December 1, 1997; 273(6): H2687 - H2695.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
T. Hussain and S. J. Mustafa
Binding of A1 Adenosine Receptor Ligand [3H]8-Cyclopentyl-1,3-Dipropylxanthine in Coronary Smooth Muscle
Circ. Res., July 1, 1995; 77(1): 194 - 198.
[Abstract] [Full Text]


Home page
ANGIOLOGYHome page
R. A. Wilson, C. Di Mario, R. Krams, Loe Kie Soei, L. Wenguang, A. C. Laird, S. H. K. The, E. Gussenhoven, P. Verdouw, and J. R. T. C. Roelandt
In Vivo Measurement of Regional Large Artery Compliance by Intravascular Ultrasound Under Pentobarbital Anesthesia
Angiology, June 1, 1995; 46(6): 481 - 488.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1992 by the American Society for Pharmacology and Experimental Therapeutics.